4.7 Article

Neurotrophins and their receptors stimulate melanoma cell proliferation and migration

期刊

JOURNAL OF INVESTIGATIVE DERMATOLOGY
卷 128, 期 8, 页码 2031-2040

出版社

ELSEVIER SCIENCE INC
DOI: 10.1038/jid.2008.21

关键词

-

向作者/读者索取更多资源

Melanoma is a highly aggressive skin tumor that originates in the epidermis from melanocytes. As melanocytes share with the nervous system a common neuroectodermal origin and express all neurotrophins (NTs), we evaluated the expression and function of NTs and their receptors in melanoma. We report that primary and metastatic melanoma cell lines synthesize and secrete all NTs. Moreover, melanoma cells express the low-affinity (p75NTR) and the high-affinity tyrosine kinase NT receptors (Trk). The inhibition of Trk receptors by either K252a or Trk/Fc chimeras prevents proliferation, indicating that autocrine NTs are responsible for this effect. NT-3, NT-4, and nerve growth factor (NGF) induce cell migration, with a stronger effect on metastatic cell lines. Transfection with p75NTR small interfering RNA (p75NTRsiRNA) or treatment with K252a inhibits NT-induced melanoma cell migration, indicating that both the low- and high-affinity NT receptors mediate this effect. All melanoma cell lines express the p75NTR coreceptor sortilin by which proNGF stimulates migration in melanoma cells, but not in cells transfected with p75NTRsiRNA. These results indicate that NTs, through their receptors, play a critical role in the progression of melanoma.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Dermatology

Comparison of Different Anti-Demodex Strategies: A Systematic Review and Meta-Analysis

Jiahua Li, Erdong Wei, Amin Reisinger, Lars Einar French, Benjamin M. Clanner-Engelshofen, Markus Reinholz

Summary: This study aims to evaluate the effectiveness of different anti-Demodex strategies and provide objective observations based on quantified Demodex mite data. The results show that ivermectin, ivermectin-metronidazole, and tea tree oil are promising interventions against Demodex. In addition to traditional pharmacotherapy, light therapies, especially IPL, and skin cleansing can also be considered effective methods for controlling Demodex infestation.

DERMATOLOGY (2023)

Review Dermatology

Acute Generalized Exanthematous Pustulosis: Clinical Characteristics, Pathogenesis, and Management

Pia-Charlotte Stadler, Anna Oschmann, Katrin Kerl-French, Julia-Tatjana Maul, Eva Maria Oppel, Barbara Meier-Schiesser, Lars Einar French

Summary: Acute generalized exanthematous pustulosis (AGEP) is a potentially severe adverse cutaneous drug reaction that manifests as numerous sterile subcorneal pustules on erythematous skin. It can be associated with organ manifestations and typically resolves rapidly upon removal of the culprit drug and adequate steroid therapy. Recent experimental data suggest an early role of drug-induced innate immune activation and innate cytokines in the pathogenesis of AGEP.

DERMATOLOGY (2023)

Review Dermatology

Cutaneous lichenoid drug eruptions: A narrative review evaluating demographics, clinical features and culprit medications

Julia-Tatjana Maul, Carole Guillet, Anna Oschmann, Lara Valeska Maul, Barbara Meier-Schiesser, Pia-Charlotte Stadler, Lars E. French, Katrin Kerl

Summary: Cutaneous lichenoid drug eruptions (LDE) are rare adverse drug reactions (ADR) that resemble lichen planus and are mainly induced by checkpoint inhibitors (CKI), tyrosine kinase inhibitors (TKI), and anti-TNF-alpha monoclonal antibodies. Diagnosis and treatment of LDE are challenging, and discontinuation of the culprit drug is not always necessary.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Dermatology

Pharmacology of orismilast, a potent and selective PDE4 inhibitor

Jonathan I. I. Silverberg, Lars E. E. French, Richard B. B. Warren, Bruce Strober, Kim Kjoller, Morten O. A. Sommer, Philippe Andres, Jakob Felding, Anne Weiss, Deniz Tutkunkardas, Tine Skak-Nielsen, Emma Guttman

Summary: This study examined the PDE4 enzymatic activity and anti-inflammatory effects of orismilast in vitro, ex vivo, and in vivo. The results showed that orismilast selectively and potently inhibited PDE4 and demonstrated broad-spectrum anti-inflammatory activity. These findings support the clinical development of oral orismilast as a novel treatment option for chronic inflammatory skin diseases.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Dermatology

Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets

Richard B. B. Warren, Bruce Strober, Jonathan I. I. Silverberg, Emma Guttman, Philippe Andres, Jakob Felding, Deniz Tutkunkardas, Kim Kjoller, Morten O. A. Sommer, Lars E. E. French

Summary: This study aimed to examine the efficacy and safety of orismilast for psoriasis treatment. The phase 2a trial found that orismilast significantly improved the condition of patients with psoriasis. The phase 1 trial tested new formulations to minimize gastrointestinal adverse reactions.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2023)

Article Education, Scientific Disciplines

eImmunonkologie: Development and Launch of a Virtual Education Platform for the Immunotherapy of Cutaneous Neoplasms

Matthias D. D. Kaufmann, Theresa Steeb, Anja Wessely, Marion Meyerolbersleben, Lars E. E. French, Carola Berking, Markus V. V. Heppt

Summary: The use of immunotherapies has greatly expanded treatment options and improved prognosis for advanced cancer patients in the past decade. We have developed a virtual teaching module called eImmunonkologie, which is the first interdisciplinary virtual course on immuno-oncology for medical students in German-speaking countries.

MEDICAL SCIENCE EDUCATOR (2023)

Article Biology

A Novel In Vivo Active Pemphigus Model Targeting Desmoglein1 and Desmoglein3: A Tool Representing All Pemphigus Variants

Roberta Lotti, Claudio Giacinto Atene, Emma Dorotea Zanfi, Matteo Bertesi, Carlo Pincelli, Tommaso Zanocco-Marani

Summary: Researchers have developed new active models to mimic the main forms of Pemphigus, including PV and mucocutaneous Pemphigus. Immunized animals and animals that received splenocytes from the immunized donors produced high concentrations of circulating antibodies against specific antigens, but the effectiveness of treatment with corticosteroids was limited.

BIOLOGY-BASEL (2023)

Article Immunology

Tumor lysis syndrome induced by tebentafusp

Theresa Ruf, Anna Leonhardt, David Anz, Wolfgang G. Kunz, Natascha Roehrle, Paul Foerster, Dirk Tomsitz, Lars Einar French, Marlene Seegraeber, Lucie Heinzerling

Summary: Tebentafusp has been approved as a new treatment for HLA-A*02:01-positive uveal melanoma patients and can improve their survival. However, it may induce cytokine-release syndrome and tumor lysis syndrome, which are potential life-threatening conditions. It is important for healthcare professionals to be aware of these adverse events and promptly treat them.

IMMUNOTHERAPY (2023)

Article Oncology

CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes

Marika Quadri, Natascia Tiso, Francesco Musmeci, Maria I. I. Morasso, Stephen R. R. Brooks, Luca Reggiani Bonetti, Rossana Panini, Roberta Lotti, Alessandra Marconi, Carlo Pincelli, Elisabetta Palazzo

Summary: This study found differential expression of CD271 in low-risk and high-risk cSCC tumors, and demonstrated that CD271 activity can decrease the proliferation and invasiveness of cSCC, while promoting tumor cell differentiation. CD271 also inhibits the metastatic process of cSCC and increases sensitivity to therapy. Therefore, CD271 may be a promising target for future pharmaceutical development.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2023)

Article Immunology

Blocking soluble Fas Ligand ameliorates pemphigus: PC111 efficacy in ex-vivo human pemphigus models

Roberta Lotti, Jennifer E. Hundt, Ralf J. Ludwig, Brydon Bennett, Antonino Amato, Alessandra Marconi, Carlo Pincelli

Summary: Pemphigus is a life-threatening autoimmune bullous disease that affects the skin and mucous membranes. Current therapies aim to suppress the immune system, but PC111, a fully human monoclonal antibody targeting Fas ligand, has shown promising results in reducing blister formation. In vitro and in vivo experiments have confirmed the mechanism of action and efficacy of PC111 in preventing acantholysis.

FRONTIERS IN IMMUNOLOGY (2023)

Article Pharmacology & Pharmacy

3D human foreskin model for testing topical formulations of sildenafil citrate

Greta Camilla Magnano, Marika Quadri, Elisabetta Palazzo, Roberta Lotti, Francesca Loschi, Stefano Dall'Acqua, Michela Abrami, Francesca Larese Filon, Alessandra Marconi, Dritan Hasa

Summary: This study aimed to investigate the loading of sildenafil citrate in three commercial transdermal vehicles using 3D full-thickness skin equivalent and compare the results with permeability experiments using porcine skin. The results showed that the results obtained using the 3D skin equivalent were comparable to those obtained using porcine skin, suggesting that the 3D skin model can be a valid alternative for ex-vivo skin absorption experiments.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2024)

Review Dermatology

Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications

Takashi K. Satoh, Matthias Munoz Neulinger, Pia-Charlotte Stadler, Rui Aoki, Lars E. French

Summary: Immune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, but they can also lead to immune-related adverse events (irAEs), including severe cutaneous reactions such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). This study analyzed 95 cases of ICI-induced SJS/TEN and found that PD-1 inhibitors were most commonly associated with these reactions. SJS/TEN typically occurred within the first 4 weeks of treatment, and corticosteroid monotherapy was the most frequently chosen treatment approach. The overall mortality rate of ICI-induced SJS/TEN was high.

JOURNAL OF DERMATOLOGY (2023)

暂无数据